ArticleHypertension (Dallas, Tex. : 1979)2011

Augmented rififylin is a risk factor linked to aberrant cardiomyocyte function, short-QT interval and hypertension.

Kathirvel Gopalakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.